About the regulatory context: How has the platform adapted since the FDA resolved the semaglutide and tirzepatide shortages
Common Off-Label Uses Polycystic Ovary Syndrome (PCOS) Some providers prescribe GLP-1s to improve insulin resistance, weight-related symptoms, and menstrual regularity Small studies show potential benefits Infertility / Preconception Support Off-label use in people trying to conceive (especially those with an elevated BMI and/or insulin resistance)
GLP-1 is a hormone that is naturally secreted by the intestines and plays a role in controlling hunger levels, blood sugar regulation, and the digestive process
The concept of 'stacking' combining multiple pharmacological agents to achieve enhanced body composition outcomes is largely driven by online forums, social media communities, and unregulated wellness markets rather than clinical science
This article examines the current evidence, safety considerations, and appropriate clinical context for tirzepatide use in patients with Hashimoto's disease